XENE logo

Xenon Pharmaceuticals (XENE)

Profile

Full Name

Xenon Pharmaceuticals Inc.

Ticker Symbol

XENE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

November 5, 2014

Indexes

Not included

Website

http://www.xenon-pharma.com

Employees

316

Key Details

Price

$30.71

Market Cap

$2.35B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$3.01(-10.26% YoY)

PE Ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$30.71
XENE price is $30.71

Price All-time High

$50.04
XENE price is currently -38.63% below its historical high of $50.04

Price Today Change

-1.88%
XENE price is down -1.88% today

Price YTD Change

-21.7%
XENE price is down -21.7% since January 1st

Price 1-year Change

-27.11%
XENE price is down -27.11% year-on-year

Price 3-year Change

-5.1%
XENE price is down -5.1% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$2.35B
XENE market capitalization is $2.35 billion

Market Cap 3-year Change

+36.9%
XENE market capitalization is up +36.9% over the past 3 years

Market Cap All-time High

$3.77B
XENE market capitalization is currently -37.67% below its historical high of $3.77 billion

Market Cap Sector Rank

84.33%
XENE market capitalization is higher than 84.33% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.44%
XENE shares outstanding is up +1.44% year-on-year

Shares Outstanding 3-Year Change

+44.26%
XENE shares outstanding is up +44.26% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.78
XENE beta is 0.78

200-day SMA

$39.66
XENE price is currently -22.57% below its 200-day simple moving average

50-day SMA

$37.13
XENE price is currently -17.29% below its 50-day simple moving average

RSI

28.87
XENE 14-day relative strength index is 28.87

Volume

1.66
XENE 30-day relative volume is 1.66

ATR

$1.54
XENE average true range is $1.54

10-day Historical Volatility

55.28%
XENE 10-day historical volatility is 55.28%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
XENE annual revenue value is unknown

Revenue Analysts Estimate

$2.33M
XENE annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year Change

-
XENE annual revenue 1-year change is unknown

Revenue Sector Rank

-
XENE annual revenue is unknown

EPS

EPS

-$3.01
XENE annual earnings per share is -$3.01

EPS Analysts Estimate

-$4.07
XENE annual earnings per share is currently -25.97% lower than the consensus analysts' forecast

EPS 1-year Change

-10.26%
XENE annual earnings per share is down -10.26% year-on-year

EPS Sector Rank

28.96%
XENE annual earnings per share is higher than 28.96% of companies in Healthcare sector

Profit

Gross Profit

-
XENE annual gross profit value is unknown

Gross Margin

-
XENE annual gross profit margin value is unknown

Operating Profit

-$279.30M
XENE annual operating income is -$279.30 million

Operating Margin

-
XENE annual operating profit margin value is unknown

Net Income

-$234.33M
XENE annual net profit is -$234.33 million

Net Margin

-
XENE annual net profit margin value is unknown

Expenses

Total Expenses

$279.30M
XENE annual total expenses is $279.30 million

Operating Expenses

$279.30M
XENE annual total operating expenses is $279.30 million

Cost Of Goods Sold

-
XENE annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$68.90M
XENE annual SGA is $68.90 million

Depreciation And Amortization

$2.56M
XENE annual depreciation & amortization is $2.56 million

Interest Expense

-
XENE annual interest expense value is unknown

Income Tax

-$4.09M
XENE annual income tax is -$4.09 million

EBIT & EBITDA

EBIT

-$279.30M
XENE annual earnings before interest & taxes is -$279.30 million

EBITDA

-$276.74M
XENE annual EBITDA is -$276.74 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$798.14M
XENE annual total assets is $798.14 million

Non Current Assets

$162.88M
XENE annual long term assets is $162.88 million

Current Assets

$635.26M
XENE annual total current assets is $635.26 million

Cash And Cash Equivalents

$142.71M
XENE annual cash & cash equivalents is $142.71 million

Accounts Receivable

$1.47M
XENE annual accounts receivable is $1.47 million

Inventory

-
XENE annual inventory value is unknown

Liabilities

Total Liabilities

$43.24M
XENE annual total liabilities is $43.24 million

Long Term Liabilities

$7.65M
XENE annual total long term liabilities is $7.65 million

Current Liabilities

$35.59M
XENE annual total current liabilities is $35.59 million

Accounts Payable

$5.07M
XENE annual accounts payable is $5.07 million

Debt

Total Debt

$9.02M
XENE annual total debt is $9.02 million

Total Debt 1-year Change

-17.32%
XENE annual total debt is down -17.32% year-on-year

Long Term Debt

$7.65M
XENE annual long term debt is $7.65 million

Short Term Debt

$1.37M
XENE annual short term debt is $1.37 million

Equity & Capital

Shareholders Equity

$754.90M
XENE annual stockholders equity is $754.90 million

Book Value

$754.90M
XENE annual book value is $754.90 million

Retained Earnings

-$899.47M
XENE annual retained earnings is -$899.47 million

Working Capital

$599.67M
XENE annual working capital is $599.67 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$181.39M
XENE annual cash flow from operations is -$181.39 million

Cash From Operations 1-year Change

-20.04%
XENE annual cash flow from operations is down -20.04% year-on-year

Cash From Investing

$165.00M
XENE annual cash flow from investing activities is $165.00 million

Cash From Investing 1-year Change

+248.13%
XENE annual cash flow from investing activities is up +248.13% year-on-year

Cash From Financing

$12.13M
XENE annual cash flow from financing activities is $12.13 million

Cash From Financing 1-year Change

-96.57%
XENE annual cash flow from financing activities is down -96.57% year-on-year

CAPEX

CAPEX

-
XENE annual capital expenditures value is unknown

CAPEX 1-year Change

-
XENE annual capital expenditures 1-year change is unknown

Free Cash Flow

Free Cash Flow

-$184.46M
XENE annual free cash flow is -$184.46 million

Free Cash Flow 1-year Change

-17.7%
XENE annual free cash flow is down -17.7% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
XENE annual gross profit margin value is unknown

Operating Margin

-
XENE annual operating profit margin value is unknown

Net Margin

-
XENE annual net profit margin value is unknown

ROA & ROE

ROA

-29.36%
XENE annual return on assets is -29.36%

ROE

-31.04%
XENE annual return on equity is -31.04%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
XENE price to earnings ratio value is unknown

PE Ratio Sector Rank

-
XENE price to earnings ratio is unknown

PB Ratio

PB Ratio

3.11
XENE price to book ratio is 3.11

PB Ratio Sector Rank

73.32%
XENE price to book ratio is higher than 73.32% of companies in Healthcare sector

PS Ratio

PS Ratio

-
XENE price to sales ratio value is unknown

PS Ratio Sector Rank

-
XENE price to sales ratio is unknown

Enterprise value

Enterprise Value

$2.22B
XENE enterprise value is $2.22 billion

Enterprise Value Sector Rank

82.88%
XENE enterprise value is higher than 82.88% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.01
XENE EV/EBITDA is -8.01

EV/EBITDA Sector Rank

13.34%
XENE EV/EBITDA is higher than 13.34% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

17.85
XENE annual current ratio is 17.85

Quick Ratio

-
XENE annual quick ratio value is unknown

Leverage

Debt To Equity

0.01
XENE annual debt to equity ratio is 0.01

Interest Coverage Ratio

-
XENE annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
XENE piotroski f-score value is unknown

Altman Z-Score

-
XENE altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Feb 24, 25 HC Wainwright & Co.
Buy
Feb 11, 25 Deutsche Bank
Buy
Dec 12, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Needham
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Oct 1, 24 HC Wainwright & Co.
Buy
Sep 3, 24 RBC Capital
Outperform
Aug 12, 24 Needham
Buy
Aug 9, 24 Wedbush
Outperform
Aug 9, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

FOLD logo
Amicus Therapeutics (FOLD)
Metsera (MTSR)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
AMRX logo
Amneal Pharmaceuticals (AMRX)
TMDX logo
TransMedics (TMDX)
IBRX logo
ImmunityBio (IBRX)
GeneDx Holdings (WGS)
LFST logo
LifeStance Health (LFST)
QDEL logo
QuidelOrtho (QDEL)
  • What is the ticker symbol for Xenon Pharmaceuticals?
  • Does Xenon Pharmaceuticals pay dividends?
  • What sector is Xenon Pharmaceuticals in?
  • What industry is Xenon Pharmaceuticals in?
  • What country is Xenon Pharmaceuticals based in?
  • When did Xenon Pharmaceuticals go public?
  • Is Xenon Pharmaceuticals in the S&P 500?
  • Is Xenon Pharmaceuticals in the NASDAQ 100?
  • Is Xenon Pharmaceuticals in the Dow Jones?
  • When was Xenon Pharmaceuticals's last earnings report?
  • When does Xenon Pharmaceuticals report earnings?
  • Should I buy Xenon Pharmaceuticals stock now?

What is the ticker symbol for Xenon Pharmaceuticals?

The ticker symbol for Xenon Pharmaceuticals is NASDAQ:XENE

Does Xenon Pharmaceuticals pay dividends?

No, Xenon Pharmaceuticals does not pay dividends

What sector is Xenon Pharmaceuticals in?

Xenon Pharmaceuticals is in the Healthcare sector

What industry is Xenon Pharmaceuticals in?

Xenon Pharmaceuticals is in the Biotechnology industry

What country is Xenon Pharmaceuticals based in?

Xenon Pharmaceuticals is headquartered in Canada

When did Xenon Pharmaceuticals go public?

Xenon Pharmaceuticals's initial public offering (IPO) was on November 5, 2014

Is Xenon Pharmaceuticals in the S&P 500?

No, Xenon Pharmaceuticals is not included in the S&P 500 index

Is Xenon Pharmaceuticals in the NASDAQ 100?

No, Xenon Pharmaceuticals is not included in the NASDAQ 100 index

Is Xenon Pharmaceuticals in the Dow Jones?

No, Xenon Pharmaceuticals is not included in the Dow Jones index

When was Xenon Pharmaceuticals's last earnings report?

Xenon Pharmaceuticals's most recent earnings report was on Feb 27, 2025

When does Xenon Pharmaceuticals report earnings?

The next expected earnings date for Xenon Pharmaceuticals is May 9, 2025

Should I buy Xenon Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page